RxSight Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$22.2M
Doctors Paid
8,158
Transactions
20,459
2024 Total
$12.3M
Payment Breakdown by Category
Research$7.1M (32.1%)
Consulting$3.3M (14.9%)
Food & Beverage$927,095 (4.2%)
Travel$17,871 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10.7M | 31 | 48.2% |
| Unspecified | $7.1M | 2,330 | 32.1% |
| Consulting Fee | $3.3M | 571 | 14.9% |
| Food and Beverage | $927,095 | 16,741 | 4.2% |
| Education | $55,766 | 53 | 0.3% |
| Gift | $50,258 | 130 | 0.2% |
| Travel and Lodging | $17,871 | 36 | 0.1% |
| Honoraria | $15,283 | 561 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,000 | 1 | 0.0% |
| Entertainment | $697.11 | 5 | 0.0% |
Payments by Type
General
$15.0M
18,129 transactions
Research
$7.1M
2,261 transactions
Ownership
$0
69 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | $5.1M | 34 | 2,032 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) IN SUBJECTS DESIRING AN EXTENDED DEPTH OF FOCUS | $1.3M | 15 | 141 |
| Clinical Outcomes of Patients Bilaterally Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $480,500 | 0 | 38 |
| Clinical Outcomes of Patients Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $61,300 | 0 | 17 |
| BINOCULAR CUSTOM VISION UTILIZING THE LIGHT ADJUSTABLE LENS (LAL) | $42,915 | 1 | 1 |
| Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery | $31,948 | 13 | 25 |
| CLINICAL OUTCOMES OF PATIENTS IMPLANTED WITH THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $11,200 | 3 | 3 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF PERFORMING 0.50 DIOPTER ASTIGMATISM CORRECTION ON THE COMMERCIALLY AVAILABLE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $9,700 | 2 | 3 |
| ActiveShield US Data Collection PMCS-002 | $3,461 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Mr. Joel Muirhead, M. D, M. D | Ophthalmology | Longview, TX | $66,074 | $0 |
| Frank Bucci, Md, MD | Ophthalmology | Wilkes Barre, PA | $60,545 | $0 |
| Dr. Sheri Rowen, Md, MD | Ophthalmology | Newport Beach, CA | $59,084 | $0 |
| Andrew Kopstein, Md, MD | Ophthalmology | Tacoma, WA | $53,958 | $0 |
| Deborah Ristvedt, D.o, D.O | Ophthalmology | Alexandria, MN | $53,864 | $0 |
| Robert Weinstock, Md, MD | Ophthalmology | Largo, FL | $52,117 | $0 |
| Gang Hu, M.d, M.D | Ophthalmology | Hurst, TX | $45,794 | $0 |
| Dr. Neda Nikpoor, M.d, M.D | Ophthalmology | Honolulu, HI | $44,495 | $0 |
| Dr. Keith Liang, M.d, M.D | Ophthalmology | Sacramento, CA | $43,317 | $0 |
| Kenneth Maverick, M.d, M.D | Ophthalmology | San Antonio, TX | $42,960 | $0 |
| Kyle Rhodes, Md, MD | Ophthalmology | Lakeway, TX | $42,690 | $0 |
| Dr. Taylor Strange, D.o, D.O | Ophthalmology | Fort Worth, TX | $40,134 | $0 |
| Dr. Farrell Tyson, M.d, M.D | Ophthalmology | Cape Coral, FL | $37,826 | $0 |
| James Davies, M.d, M.D | Ophthalmology | Oceanside, CA | $36,900 | $0 |
| Jenny Wong, Od, OD | Optometrist | Las Vegas, NV | $30,125 | $0 |
| Dr. Lance Kugler, Md, MD | Ophthalmology | Omaha, NE | $27,889 | $0 |
| Dr. Jonathan Seidenberg, M.d, M.D | Ophthalmology | Havre De Grace, MD | $27,079 | $0 |
| Dr. Jennifer Wong, O.d, O.D | Optometrist | Chicago, IL | $24,241 | $0 |
| Brandon Baartman, M.d, M.D | Ophthalmology | Omaha, NE | $22,939 | $0 |
| Dr. Jay Schwartz, Do, DO | Ophthalmology | Scottsdale, AZ | $22,226 | $0 |
| Dr. Christopher Pole, M.d, M.D | Ophthalmology | Overland Park, KS | $19,200 | $0 |
| Dr. Audrey Rostov, Md, MD | Ophthalmology | Bellevue, WA | $18,391 | $0 |
| Dr. Eva Kim, Md, MD | Ophthalmology | Denver, CO | $17,509 | $0 |
| Mr. James Shipp, Md, MD | Ophthalmology | Oxford, MS | $16,823 | $0 |
| Bruce Grossnickle, M.d, M.D | Ophthalmology | Warsaw, IN | $16,000 | $0 |
Ad
Top Products
- RXSIGHT CONTACT LENS $16.0M
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $5.8M
Associated Products (4)
Payment Categories
- Food & Beverage $927,095
- Consulting $3.3M
- Travel & Lodging $17,871
- Research $7.1M
About RxSight Inc
RxSight Inc has made $22.2M in payments to 8,158 healthcare providers, recorded across 20,459 transactions in the CMS Open Payments database. In 2024, the company paid $12.3M. The top product by payment volume is RXSIGHT CONTACT LENS ($16.0M).
Payments were distributed across 69 medical specialties. The top specialty by payment amount is Ophthalmology ($15.0M to 3,557 doctors).
Payment categories include: Food & Beverage ($927,095), Consulting ($3.3M), Research ($7.1M), Travel & Lodging ($17,871).
RxSight Inc is associated with 4 products in the CMS Open Payments database, including RXSIGHT CONTACT LENS, LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD), and RXSIGHT INJECTOR HANDPIECE.